Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine.
about
A review of frovatriptan for the treatment of menstrual migraineGeneral lack of use of placebo in prophylactic, randomised, controlled trials in adult migraine. A systematic review.Management of menstrual migraine: a review of current abortive and prophylactic therapies.Menstrual migraine: therapeutic approachesEfficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.Genomic expression patterns in menstrual-related migraine in adolescents.Systematic Review of Preventive and Acute Treatment of Menstrual Migraine.Frovatriptan versus almotriptan for acute treatment of menstrual migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative studySymptomatic or prophylactic treatment of weekend migraine: an open-label, nonrandomized, comparison study of frovatriptan versus naproxen sodium versus no therapy.A review of the use of frovatriptan in the treatment of menstrually related migraine.Triptans in prevention of menstrual migraine: a systematic review with meta-analysisFrovatriptan vs. other triptans for the acute treatment of oral contraceptive-induced menstrual migraine: pooled analysis of three double-blind, randomized, crossover, multicenter studies.Frovatriptan for the acute treatment of migraine and prevention of predictable menstrual migraine.Acupuncture as prophylaxis for menstrual-related migraine: study protocol for a multicenter randomized controlled trial.Are the current IHS guidelines for migraine drug trials being followed?Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment.Menstrual Migraine and Treatment Options: Review.Menstrual migraine: treatment options.Menstrual migraine: a review of current and developing pharmacotherapies for women.Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)
P2860
Q27025002-99DCBB33-2A5E-4EC9-9749-285FA5D18523Q30252048-6EC28529-3355-40E4-BDEA-DDD6E25A74D0Q34338801-C9172883-5E05-4B42-9233-90E5D336DEF6Q34409246-C1B3B601-0773-4338-8964-3459AED159C0Q35522772-056181BA-AB81-46BB-8573-05604F6FF9DBQ35693298-A041119B-6A6E-4D4D-A9D5-4C937AA780F2Q35742998-8E599A33-C120-45A8-99E9-18BAC7A3AB01Q36052155-1F5F6107-A44C-4175-9EBD-F39C09398219Q36554913-01302C29-2E5F-43E1-B01D-994DA3230B60Q36638660-97A2015B-7DD2-478B-A02A-0448807A720EQ36749560-BF5C854B-B0AD-40AB-8EF0-0B828931B97BQ36865920-B101270D-2BF1-4D77-8A86-03028DD5FA86Q37154795-A4DC17A7-CEC8-4CF3-AF19-69DA754DB5EFQ37315130-01CD211F-58AC-46B5-B1F9-EAF424664ABCQ37798757-150FF46F-6E5E-49DF-B735-1F24ED79321CQ38237616-B0F1D4C2-428F-4E08-BC74-BE0F26F7CF48Q39026779-5402CA7F-900F-407A-B44E-FAD17DF06806Q39206444-D14C267C-C7FC-46DC-BA66-E5C728137E85Q50047547-DE0BC1E8-060F-4D57-A56E-BA6812EC42DDQ56976562-15827E54-2ACE-4801-ABFB-FFF522ABDED4
P2860
Frovatriptan vs. transdermal oestrogens or naproxen sodium for the prophylaxis of menstrual migraine.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Frovatriptan vs. transdermal o ...... hylaxis of menstrual migraine.
@ast
Frovatriptan vs. transdermal o ...... hylaxis of menstrual migraine.
@en
type
label
Frovatriptan vs. transdermal o ...... hylaxis of menstrual migraine.
@ast
Frovatriptan vs. transdermal o ...... hylaxis of menstrual migraine.
@en
prefLabel
Frovatriptan vs. transdermal o ...... hylaxis of menstrual migraine.
@ast
Frovatriptan vs. transdermal o ...... hylaxis of menstrual migraine.
@en
P2093
P2860
P1476
Frovatriptan vs. transdermal o ...... hylaxis of menstrual migraine.
@en
P2093
Carlo Belloni
Caterina Barrilà
Francesca Guidotti
Mario Guidotti
Michela Mauri
P2860
P2888
P304
P356
10.1007/S10194-007-0417-4
P577
2007-10-23T00:00:00Z